• Super-Enhancer Hijacking in Early LUAD

  2026-08-23

  Zhang et al. identified LINC01977 as a super-enhancer-hijacked long noncoding RNA that promotes early-stage lung adenocarcinoma through a positive-feedback circuit involving TGF-β, SMAD3, and CBP/P300. The study links tumor-associated macrophage signaling to enhancer activity and provides a mechanistic framework for lung adenocarcinoma research and epigenetics research.

• HyperFluor 488 Goat Anti-Rabbit IgG Guide

  2026-08-22

  HyperFluor 488 Goat Anti-Rabbit IgG is a fluorescent secondary antibody for detecting rabbit primary antibodies in immunofluorescence, microscopy, immunohistochemistry, and flow cytometry workflows. It should not be used as a substitute for a secondary matched to non-rabbit primaries, and its sodium azide-containing formulation requires compatibility checks for live-cell or azide-sensitive assays.

• Dual Recombinase Tracing Rules Out Mouse Neo-Oogenesis

  2026-08-21

  Xie, Zhou, and Zheng combine Cre-loxP and Dre-rox lineage tracing to distinguish pre-existing postnatal germ cells from other ovarian cells. Across physiological aging and Busulfan-induced ovarian injury, the study detected no reporter-positive growing oocytes or metaphase II eggs, strengthening the conclusion that postnatal neo-oogenesis does not occur in vivo in mice.

• Methicillin Sodium Salt in MSSA Assays

  2026-08-21

  Build reproducible MSSA susceptibility, cell-wall inhibition, and resistance-modeling workflows with Methicillin sodium salt. This guide pairs practical assay design with the reference study’s phenotype-to-target logic, helping researchers use a defined comparator without overinterpreting MRSA results.

• Antiarrhythmic Drugs and KCa2 Channels in Atrial Fibrillatio

  2026-08-20

  The 2017 European Journal of Pharmacology study systematically tested ten antiarrhythmic drugs against human KCa2.2 and KCa2.3 channels using automated whole-cell patch clamp. Only dofetilide and propafenone inhibited these channels, and their potencies were substantially weaker than clinically relevant free drug concentrations, indicating that KCa2 modulation is unlikely to explain the principal atrial antiarrhythmic actions of Dronedarone or most comparator drugs.

• CB-5083 and the Translational Logic of p97 Inhibition

  2026-08-20

  A mechanistic and strategic analysis of CB-5083 as a p97 inhibitor, connecting protein homeostasis disruption with DNA repair, cancer biology, and translational study design.

• Rucaparib (AG-014699) in DNA Damage Assays

  2026-08-19

  Rucaparib (AG-014699) provides a high-affinity way to test how PARP1 inhibition changes DNA-break persistence, radiosensitization, and cell death. This workflow emphasizes genotype-aware prostate cancer models, orthogonal damage readouts, transporter-related confounders, and transcription-versus-death measurements.

• Tunable Human Intestinal Organoids: Study Insights

  2026-08-18

  This Nature Communications study develops a human small-intestinal organoid system that maintains strong proliferation while increasing epithelial cell diversity under a unified culture condition. Its central innovation is to enhance stem-cell potential first, then use Wnt, Notch, BMP, and BET-related perturbations to bias differentiation in a controlled and reversible manner.

• Microplastics, Nanoplastics, and Pulmonary Fibrosis

  2026-08-18

  The reference study provides a comparative in vivo and in vitro evaluation of polystyrene, polyethylene, and polypropylene particles across microplastic and nanoplastic size ranges. Its findings associate particle size and polymer identity with pulmonary injury, fibrotic remodeling, inflammation, and dysregulation of the FXR–YAP1 axis, while also outlining practical biomarker and pathway-testing strategies.

• Cinoxacin: Quinolone Antibiotic Research Guide

  2026-08-17

  Cinoxacin is a synthetic quinolone antibiotic with documented in vitro activity against many aerobic Gram-negative bacilli. Its strongest evidence base supports urinary tract infection research, susceptibility testing, bactericidal assays, and antibiotic resistance studies, while also defining important limits against Pseudomonas aeruginosa and Gram-positive organisms.

• CD38 CAR Binder Structures and Affinity Tuning

  2026-08-17

  The 2026 iScience study dissects how the CD38-targeting CAR binders RP02 and 028 recognize different antigen surfaces and alter CD38 enzymatic activity. Its structural, mutational, and cellular data show that rational attenuation of the 028 binder can reduce CAR-T fratricide while preserving antitumor cytotoxicity.

• NVP-BGJ398 Phosphate: FGFR Workflow Guide

  2026-08-16

  NVP-BGJ398 phosphate provides a practical way to interrogate FGFR1–3 signaling across genotype-defined cancer models and FGFR3-driven chondrocyte systems. This guide connects assay design, formulation, pathway readouts, and troubleshooting to the findings of a mouse study of SLC26A2-related chondrodysplasia.

• SMC2 and SMC4 Prognostic Markers in Breast Cancer

  2026-08-15

  This 2024 study integrates multi-database bioinformatics with cell and xenograft experiments to identify SMC2 and SMC4 as independent prognostic factors in breast cancer. Its functional data further suggest that suppressing either gene increases MCF7 sensitivity to 5-fluorouracil and oxaliplatin, although the findings require validation in larger clinical cohorts and additional breast cancer models.

• Functional Metagenomics Finds Potent Cas9 Inhibitors

  2026-08-15

  Forsberg et al. developed a functional metagenomic selection that recovered ten DNA fragments capable of inhibiting Streptococcus pyogenes Cas9 from human oral and fecal microbiomes. The study identified AcrIIA11 as a potent, mechanistically distinctive inhibitor active in bacteria and human cells, demonstrating how functional screening can reveal anti-CRISPR diversity missed by sequence-based searches.

• CNQX for AMPA/Kainate Circuit Dissection

  2026-08-14

  CNQX is a practical way to separate AMPA/kainate-driven excitation from NMDA-dependent signaling in neuronal and cardiovascular circuit assays. This guide translates receptor pharmacology and a recent cNTS–PVN study into executable workflows, controls, and troubleshooting strategies.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page